Cambridge-based start-up company Bicycle Therapeutics has recently raised £40 million from a range of investors to bring its cancer drug candidates to clinical trials.
Celebrating young sustainability innovators
Are strict IP policies harming the development of sustainable technologies? In this article for The Conversation, Frank Tietze from the Institute for Manufacturing investigates how the open source approach taken by companies such as Tesla may help the economy and the planet.
A University of Cambridge spin-out company has raised £7 million in new funding, which will help in the development of treatments for liver and lung disease.
Cambridge Academy of Therapeutic Sciences aims to create world-leading industry-academia collaborations09 Mar 2017
The Cambridge Academy of Therapeutic Sciences (CATS), a new initiative that aims to establish a world-leading platform for collaboration between academia and industry in the development of therapeutics, will be launched today by the Vice-Chancellor of the University of Cambridge.
Collaboration between business and academia can identify the most urgent research priorities to ensure the sustainability of food, energy, water and the environment, according to a new study.
Cambridge spin-out Carrick Therapeutics raises $95 million in funding, representing the largest-ever early stage investment in a UK university spin-out company.
New study identifies four strategies and two key methods for scaling up social businesses in developing countries in order to meet the unmet needs of more than four billion people.
Why is Milton Keynes one of the most successful cities in the UK, and Dundee one of the least? What gives Leeds its economic edge over Liverpool? How did London survive the 1990s recession, going from boom to bust and boom again? Researchers are asking these questions and many more in the largest ever analysis of what makes cities thrive.